3
Announcements
Trials
Browse
Landscape
Status
Completed
4
Active not recruiting
2
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Sarcoma
1
Radiation Injuries
1
Osteosarcoma
1
Neoplasms, Second Primary
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Mobility Limitation
1
Hyperthermia
1
Congenital Abnormalities
1
Cognitive Dysfunction
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
pembrolizumab
38
Blood Specimen Collection
38
Bevacizumab
22
Surveys and Questionnaires
18
Standard of Care
18
Radiotherapy
17
Exercise
17
Carboplatin
17
Nivolumab
15
atezolizumab
14
Paclitaxel
14
Cisplatin
14
Drug Therapy
13
Fluorouracil
12
Cyclophosphamide
12
Cetuximab
11
Trastuzumab
10
Pemetrexed
10
Leucovorin
10
Docetaxel
10
Dexamethasone
10
Oxaliplatin
9
Biopsy
9
pertuzumab
8
olaparib
8
Temozolomide
8
Panitumumab
8
Observation
8
Irinotecan
8
abemaciclib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms
×
Patient Reported Outcome Measures
×
Clear all
NCT04151342
2025-12-03
CARMA-BROS
University Health Network, Toronto
Recruiting
5,500 enrolled